SCOPE AND LIMITATIONS OF A GENERAL UNKNOWN SCREENING BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY IN ACUTE-POISONING

被引:16
作者
KOPPEL, C [1 ]
TENCZER, J [1 ]
机构
[1] LANDESINST GERICHTLICHE & SOZIALE MED,DEPT FORENS TOXICOL,BERLIN,GERMANY
关键词
D O I
10.1016/1044-0305(95)00585-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The gold standard for the diagnosis of acute poisoning is toxicological analysis. Because information on the incorporated toxic substance provided by the patient or his relatives is known from experience to be unreliable in about 40% of all intoxications, a screening procedure that covers most relevant drugs and toxicants is required rather than an analytical procedure optimized for the identification of a single class of substances. The special task for a general unknown screening procedure is to identify a toxic substance among endogenous or food-derived substances as well as environmental toxicants in a biological matrix on an emergency basis. Because the unknown toxic substance may vary considerably in its physicochemical properties and its concentration range, a universally applicable screening procedure is required. Although gas chromatography-mass spectrometry has been used for three decades, it still offers many unique advantages in terms of sensitivity, specificity, reliability, and coverage of a large number of toxic substances. Because the procedure has to be kept as simple and as short as possible, compromises have to be made with respect to extraction, derivatization, and mass-spectral techniques. The specimen of choice for a general unknown screening is-if available-urine. The standard mode of ionization is electron impact. The identification of unknown substances is highly challenging because, in our experience, previously unknown metabolites may be detected rather frequently in acute poisoning. Although an automated mass spectra library search considerably facilitates the identification process, expert knowledge on the identification of substances not included in the library as well as knowledge in clinical toxicology and metabolism is indispensable.
引用
收藏
页码:995 / 1003
页数:9
相关论文
共 34 条
[1]   AUTOMATED LIQUID-CHROMATOGRAPHIC ANALYSIS OF DRUGS IN URINE BY ONLINE SAMPLE CLEANUP AND ISOCRATIC MULTICOLUMN SEPARATION [J].
BINDER, SR ;
REGALIA, M ;
BIAGGIMCEACHERN, M ;
MAZHAR, M .
JOURNAL OF CHROMATOGRAPHY, 1989, 473 (02) :325-341
[2]   HIGH-SPEED LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY FOR THE DETERMINATION OF DRUGS IN BIOLOGICAL SAMPLES [J].
COVEY, TR ;
LEE, ED ;
HENION, JD .
ANALYTICAL CHEMISTRY, 1986, 58 (12) :2453-2460
[3]  
DEUTSCH DG, 1985, CLIN CHEM, V31, P741
[4]  
DEZEEUW RA, 1994, J CHROMATOGR A, V674, P3, DOI 10.1016/0021-9673(94)85214-6
[5]  
DEZEEUW RA, 1971, TIAFT B
[6]  
DUTTFIELD AM, 1989, J CHROMATOGR, V475, P273
[7]   COMPREHENSIVE GC-MS REFERENCE DATA SYSTEM FOR TOXICOLOGICAL AND BIOMEDICAL PURPOSES [J].
FINKLE, BS ;
FOLTZ, RL ;
TAYLOR, DM .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1974, 12 (05) :304-328
[8]   GC/MS REFERENCE DATA SYSTEM FOR IDENTIFICATION OF DRUGS OF ABUSE [J].
FINKLE, BS ;
TAYLOR, DM .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1972, 10 (05) :312-&
[9]   MEASUREMENT OF ERGOTAMINE IN HUMAN-PLASMA BY TRIPLE SECTOR QUADRUPOLE MASS-SPECTROMETRY WITH NEGATIVE-ION CHEMICAL IONIZATION [J].
HAERING, N ;
SETTLAGE, JA ;
SANDERS, SW ;
SCHUBERTH, R .
BIOMEDICAL MASS SPECTROMETRY, 1985, 12 (05) :197-199
[10]  
HENION JD, 1986, MASS SPECTROMETRY BI